Document ID: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-4_18-cv-05769/USCOURTS-cand-4_18-cv-05769-0/pdf.json

Parties Involved:
Bausch Health Companies Inc.
Defendant
Flow Pharma, Inc.
Plaintiff
Valeant Pharmaceuticals North America, LLC
Defendant

Document Text:

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

STIPULATION AND [PROPOSED] ORDERTO FILE FIRST AMENDED COMPLAINT 

CASE NO. 3:18-CV-5769-JST 

William A. Lapcevic (SBN 238893)

DiBenedetto & Lapcevic, LLP

1101 Pacific Avenue, Suite 320

Santa Cruz, California 95060

Telephone: (831) 325-2674

Facsimile: (831) 466-7617

Email: wal@dl-lawllp.com

Gary F. Wang (SBN 195656) Law Offices of Gary F. Wang 448 South Pasadena Avenue

Pasadena, CA 91105

Telephone: (626) 585-8001

Facsimile: (626) 585-8002

Email: garywang@gfwanglaw.com

Attorneys for 

Plaintiff Flow Pharma, Inc.

VENABLE LLP

Alper T. Ertas (SBN 264120)

atertas@venable.com

101 California St., Suite 3800

San Francisco, CA 94111

Telephone: (415) 653-3750

Facsimile: (415) 653-3755

VENABLE LLP

Scott K. Reed (pro hac vice) sreed@venable.com

Steven C. Kline (pro hac vice) sckline@venable.com

1290 Avenue of the Americas, 20th

Floor

New York, NY 10104-3800

Telephone: (212) 218-2100

Facsimile: (212) 218-2200

Attorneys for Defendants

Bausch Health Companies Inc.

and Valeant Pharmaceuticals North 

America, LLC

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA – SAN FRANCISCO DIVISION

FLOW PHARMA, INC.,

Plaintiff,

v.

BAUSCH HEALTH COMPANIES 

INC.; VALEANT 

PHARMACEUTICALS NORTH 

AMERICA, LLC

Defendants.

CASE NO. 3:18-cv-5769-JST

STIPULATION AND [PROPOSED] 

ORDER TO FILE FIRST AMENDED 

COMPLAINT

Case 4:18-cv-05769-JST Document 35 Filed 04/29/19 Page 1 of 5
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

STIPULATION AND [PROPOSED] ORDERTO FILE FIRST AMENDED COMPLAINT 

CASE NO. 3:18-CV-5769-JST

Plaintiff FLOW PHARMA (“Plaintiff”) and Defendants BAUSCH HEALTH 

COMPANIES INC. and VALEANT PHARMACEUTICALS NORTH AMERICA, 

LLC (hereinafter “Defendants”) jointly submit this Stipulation and [Proposed] 

Order to File First Amended Complaint. 

WHEREAS on September 20, 2018, Plaintiff filed its Complaint for Patent 

Infringement.

WHEREAS Plaintiff, Flow Pharma seeks to file its First Amended 

Complaint, which adds one cause of action for Contributory Infringement.

WHEREAS a copy of Plaintiff’s Proposed First Amended Complaint is 

attached hereto as Exhibit 1.

IT IS HEREBY STIPULATED, by and between Plaintiff and Defendants, by 

and through their respective counsel, that:

1. Plaintiff should be granted leave to amend to file its First Amended 

Complaint, a copy of which is attached hereto as Exhibit 1.

2. Plaintiff’s Motion For Leave To File First Amended Complaint 

currently scheduled for May 9, 2019 is hereby withdrawn and taken off calendar.

3. Plaintiff’s First Amended Complaint is deemed filed as of the date the 

Order is transmitted via that CM/ECF system.

Case 4:18-cv-05769-JST Document 35 Filed 04/29/19 Page 2 of 5
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

STIPULATION AND [PROPOSED] ORDERTO FILE FIRST AMENDED COMPLAINT 

CASE NO. 3:18-CV-5769-JST

Respectfully submitted,

Dated: April 23, 2019 DiBENEDETTO & LAPCEVIC, LLP

By:________/s/ William A. Lapcevic

William A. Lapcevic

Attorney for Plaintiff

Dated: April 23, 2019 VENABLE LLP

By:______/s/ Steven C. Kline______________ Steven C. Kline

Attorney for Defendants

Case 4:18-cv-05769-JST Document 35 Filed 04/29/19 Page 3 of 5
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

STIPULATION AND [PROPOSED] ORDERTO FILE FIRST AMENDED COMPLAINT 

CASE NO. 3:18-CV-5769-JST

SIGNATURE ATTESTATION

Pursuant to Civil Local Rule 5-1(i)(3), I hereby certify that concurrence in the filing of 

this document has been obtained from each of the other Signatories shown above.

Dated: April 24, 2019

By:_______/s/ William A. Lapcevic

William A. Lapcevic

Case 4:18-cv-05769-JST Document 35 Filed 04/29/19 Page 4 of 5
1 

2 

3 

4 

5 

6 

7 

8 

9 

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

STIPULATION AND [PROPOSED] ORDERTO FILE FIRST AMENDED COMPLAINT 

CASE NO. 3:18-CV-5769-JST

[PROPOSED] ORDER

Having read and considered the foregoing Stipulation, and good finding good 

cause appearing therefore:

IT IS HEREBY ORDERED that Plaintiff, FLOW PHARMA is granted 

leave to amend to file its First Amended Complaint, a copy of which is attached 

hereto as Exhibit 1. 

IT IS ALSO ORDERED that Plaintiff’s Motion For Leave To File First 

Amended Complaint currently scheduled for May 9, 2019 is hereby withdrawn and 

taken off calendar.

IT IS HEREBY ORDERED that Plaintiff’s First Amended Complaint is 

deemed filed as of the date this Order is transmitted via that CM/ECF system.

IT IS SO ORDERED.

Dated: ___________________________ ______________________

Honorable Jon S. Tigar United States District Court Judge

April 29, 2019

Plaintiff shall file its First Amended Complaint no later than 

May 3, 2019. IT IS SO ORDERED.

Case 4:18-cv-05769-JST Document 35 Filed 04/29/19 Page 5 of 5